These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 23483593

  • 1. Validation of parkinsonian disease-related metabolic brain patterns.
    Teune LK, Renken RJ, Mudali D, De Jong BM, Dierckx RA, Roerdink JB, Leenders KL.
    Mov Disord; 2013 Apr; 28(4):547-51. PubMed ID: 23483593
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S, Amtage F, Hanspal E, Vonsattel JP, Poston KL, Meyer PT, Leenders KL, Eidelberg D.
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
    Juh R, Pae CU, Lee CU, Yang D, Chung Y, Suh T, Choe B.
    Neurosci Res; 2005 Jul; 52(3):211-9. PubMed ID: 15927722
    [Abstract] [Full Text] [Related]

  • 7. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [Abstract] [Full Text] [Related]

  • 8. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S, Reinhard M, Amtage F, Guschlbauer B, Buchert R, Tüscher O, Weiller C, Niesen WD, Meyer PT.
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [Abstract] [Full Text] [Related]

  • 9. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Ge J, Wu J, Peng S, Wu P, Wang J, Zhang H, Guan Y, Eidelberg D, Zuo C, Ma Y.
    Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
    [Abstract] [Full Text] [Related]

  • 10. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W, Spehl TS, Rijntjes M, Hellwig B, Weiller C, Winkler C, Weber WA, Tüscher O, Meyer PT.
    Neurology; 2012 Sep 25; 79(13):1314-22. PubMed ID: 22914831
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.
    Acta Neurol Scand; 2013 May 25; 127(5):362-70. PubMed ID: 23406296
    [Abstract] [Full Text] [Related]

  • 12. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, Salsone M, Morelli M, Lanza PL, Quattrone A.
    Parkinsonism Relat Disord; 2011 Mar 25; 17(3):172-6. PubMed ID: 21236720
    [Abstract] [Full Text] [Related]

  • 13. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
    Eckert T, Feigin A, Lewis DE, Dhawan V, Frucht S, Eidelberg D.
    Mov Disord; 2007 Jan 15; 22(2):167-73. PubMed ID: 17133454
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic criteria of parkinsonian syndromes].
    Tison F.
    Rev Neurol (Paris); 2003 May 15; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [Abstract] [Full Text] [Related]

  • 15. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A, DeNotaris R.
    Sleep Med; 2004 Mar 15; 5(2):201-6. PubMed ID: 15033144
    [Abstract] [Full Text] [Related]

  • 16. [Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].
    Vercueil L.
    Rev Neurol (Paris); 2000 Mar 15; 156 Suppl 2 Pt 2():14-22. PubMed ID: 10916032
    [Abstract] [Full Text] [Related]

  • 17. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.
    Brain; 2006 Oct 15; 129(Pt 10):2679-87. PubMed ID: 16815875
    [Abstract] [Full Text] [Related]

  • 18. Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
    Tomše P, Rebec E, Studen A, Perovnik M, Rus T, Ležaić L, Tang CC, Eidelberg D, Trošt M.
    Phys Med; 2022 Jun 15; 98():131-138. PubMed ID: 35537328
    [Abstract] [Full Text] [Related]

  • 19. Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
    Tripathi M, Tang CC, Feigin A, De Lucia I, Nazem A, Dhawan V, Eidelberg D.
    J Nucl Med; 2016 Jan 15; 57(1):60-6. PubMed ID: 26449840
    [Abstract] [Full Text] [Related]

  • 20. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, Eidelberg D.
    Neuroimage; 2005 Jul 01; 26(3):912-21. PubMed ID: 15955501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.